Analysts' View On Buzzing Stocks Like ONGC, Pidilite, Aurobindo Pharma & More On Hot Money

Analysts' View on HDFC AMC, Shriram Transport, Aurobindo Pharma & More

Analysts discuss Sun Pharma, Godrej Ind, NTPC and other stocks

Watch Analysts Discuss Investment Prospects For Sun Pharma, JP Associates, Siemens And Arvind On Hot Money

Analysts' Technical View On Stocks Like Pidilite Ind, Arvind, Marico & More

Analysts Decode Charts Of Titan, Pidilite, Motherson Sumi and More

India's Aurobindo, Lupin Are Cheap Versus Analysts' Targets

Analysts Cautiously Optimistic Of Aurobindo Pharma's Sandoz Acquisition

India's Aurobindo, Lupin Are Cheap Versus Analysts' Targets

Analysts' View on HCC, Pharma Stocks, Midcap Stocks & More

Analysts' View on HUL, DCB Bank, Pharma Sector & More On Hot Money

Analysts' View On Buzzing Stocks Like Vedanta, Sun Pharma, Hexaware, Mahindra CIE & More

Analysts' View On Buzzing Stocks Like Sun Pharma, TVS, Tata Elxsi & More

Analysts Lose Faith In Sun Pharma & NMDC, Turn Cautious On Bharat Forge & Arvind

Hot Money: What Analysts Find Attractive In Titan, Sun Pharma, Can Fin Homes

Analysts Decode Charts Of Bajaj Finance, Ajanta Pharma & The Nifty Bank

Analysts' view on buzzing stocks like IRB Infra, Natco Pharma & Prataap Snacks

Analysts' View On L&T Tech, ADAG Stocks, Pharma Stocks & More

Analysts' View On Dewan Housing, Sun Pharma, Real Estate Stocks & More

Analysts' View On Buzzing Stocks Like Nestle, Sun Pharma, NCC & More

Aurobindo Pharma’s Unit-4 gets 14 observations from USFDA

Insights from Nikhil Kothari on New Flexi Cap Funds | NDTV Profit

LTIMindtree: Margin Outlook Stable; No CEO Succession Plans | NDTV Profit

Insider Perspective: RBI's Action Against Kotak - Rahul Malani, Sharekhan By BNP Paribas Shares Insights

Private Sector Banks Expected To Outpace PSU Banks In Earnings Growth: Analyst Pranav Gundlapalle

ImagicaaWorld Enterprises: Expansion Outlook | NDTV Profit

MAS Financial Services Growth Drivers: CMD Kamlesh Gandhi Discusses

Pidilite Industries’ Bharat Puri On Volumes, Demand & Key Driver For Growth | NDTV Profit

Pidilite MD Bharat Puri On Q1 Report Card & More

Q4 Review: Pidilite Industries Decline After Q4 Revenue Misses Estimates

Stocks In Focus | Zomato, Kansai Nerolac, MGL, Pidilite And More | BQ Prime

Q2 Review Pidilite's Net Profit & Margins Contract; What's Next

Q4 Results: Pidilite MD On Demand Scenario & Plans To Negate Cost Pressure